Search results
Found 305 matches for
Inflammatory Bowel Disease (IBD) is a chronic inflammatory disease with limited treatment options. Up to 40% of patients with IBD fail to respond to conventional therapies, partly due to our limited understanding of the cells that form the large intestine, but also how they change in in patients affected by this disease.
Chinese ambassador visits CAMS Oxford Institute
News
15 April 2024
The Chinese Ambassador to the United Kingdom, His Excellency Zheng Zeguang, visited the University of Oxford last week, where he promoted deeper educational exchanges between China and the UK. During the visit, Zheng met with Irene Tracey, Vice-Chancellor of the university, and had an in-depth discussion on the university’s collaboration with Chinese counterparts.
Francesco Boccellato receives Lee Placito Research Fellowship
News
8 April 2024
Dr Francesco Boccellato, Leadership Fellow at the Oxford Branch of the Ludwig Institute for Cancer Research has recently been awarded the Lee Placito Research Fellowship in Gastrointestinal Cancer.
Oxford hosts Belgian vaccine experts
News
5 April 2024
Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.
OUCRU celebrates World Health Worker Week 2024
News
4 April 2024
In the first week of April each year, the global community comes together to celebrate health workers, the backbone of the health industry and society.
Developing the world's first lung cancer vaccine
News
26 March 2024
Researchers at the Nuffield Department of Medicine, the Francis Crick Institute and University College London have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine. The group includes Professor Tim Elliott, Kidani Professor of Immuno-oncology at NDM.
CMD partners with Ono Pharmaceutical Co for translational research
News
25 March 2024
The Centre for Medicines Discovery (CMD) at NDM, has recently partnered with Ono Pharmaceutical Co (Ono) to validate and develop novel targets in a bid to discover innovative medicines.
Blog: Advancing tuberculosis research and elimination strategies
News
22 March 2024
In this blog, Dr Marco Polo Peralta, a senior scientist at NDM’s Jenner Institute provides insight into his research work on tuberculosis and shares how he thinks the 2030 TB elimination goal can be achieved.
New Pandemic PACT research programme launched
News
21 March 2024
The Pandemic Sciences Institute at NDM, in collaboration with the global coalition of health research funders GloPID-R and UKCDR, has launched a new research programme including an interactive platform to track and analyse over $7 billion in global pandemic research funding.
New bronchoscopy facility expands capacity for respiratory trials
News
15 March 2024
The Oxford Experimental Medicine Clinical Research Facility hosted by the Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences has expanded its capability to undertake research bronchoscopies. The facility welcomed its first volunteers as part of the Oxford Airways Study to help understand the causes of asthma.
UK’s first registry to be set up for those at risk of type 1 diabetes
News
11 March 2024
Researchers from the Oxford BRC and other collaborating organisations have received funding to set up a UK registry for children and adults who are at risk of type 1 diabetes and have tested positive for diabetes autoantibodies.
Dr Suwarti’s leadership inspires growth at OUCRU Indonesia
News
8 March 2024
Dr Suwarti (Atie) began her journey with OUCRU Indonesia in 2018 as an awardee of the OUCRU Young Scientist Fellowship programme, when she embarked on a research journey into leptospirosis, a neglected tropical disease. Her curiosity and commitment to improving health outcomes have seen her research interests expand to the molecular diagnostic of Tuberculosis, Covid-19, and HIV.
Research team receives $25m Cancer Grand Challenges award
Awards News
7 March 2024
A global, interdisciplinary team of researchers, including the Centre for Medicines Discovery’s Professor Frank von Delft, has been selected to receive a Cancer Grand Challenges award of up to $25m over five years to tackle the solid tumours in children challenge. The Cancer Grand Challenges PROTECT team is led by Professor Stefan Pfister of the Hopp Children's Cancer Center in Heidelberg.
OUCRU partner hospital receives Viet Nam medical achievement award
Awards News
1 March 2024
Oxford University Clinical Research Unit’s host and partner in Ho Chi Minh City, the Hospital for Tropical Diseases, was recently honoured with the Vietnam 2023 Medical Achievement Award at an event hosted by Voice of Ho Chi Minh City (VoH).
New project uses extreme weather data to inform health system capacity
News
28 February 2024
Led by Benjamin Tsofa and Jacob McKnight, at the KEMRI-Wellcome Trust Research Programme, a new project called "A Novel Extreme Weather Risk Insurance System for Kenya (NEWRISK)” will focus on using the latest methods to provide focused data on extreme weather, population vulnerability, and health system capacity readiness across various climatic zones in Kenya.
ASAP Discovery Consortium wins 2023 FASEB Dataworks prize
Awards News
8 February 2024
The AI-driven Structure-enabled Antiviral Platform (ASAP) has won an Exemplary Achievement Award from the Federation of American Societies for Experimental Biology (FASEB) and the National Institutes of Health (NIH). The prize recognises data practices in biological and biomedical research labs during the active phase of research.
New teaching collaboration with Brazilian universities
News
6 February 2024
The University of Oxford has entered into an agreement with three Brazilian universities, to contribute to the delivery of an undergraduate course in ‘Translational Science’, starting in 2024. The course will teach the full journey of a product ‘from bench to bedside’ as part of any science degree to prepare the next generation of researchers for the translation of their laboratory discoveries into patient care and prevention.
UK minister meets with Oxford pandemic researchers
News
29 January 2024
Researchers at the Jenner Institute, the Oxford Vaccine Group and the Pandemic Sciences Institute hosted the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.
New NIHR Oxford Senior Research Fellows named
Awards News
17 January 2024
Researchers from a wide range of disciplines have been appointed to be the next cohort of NIHR Oxford Senior Research Fellows - seven mid-career researchers identified as having the potential to become future translational research leaders. The cohort includes Dr Matthias Friedrich from the Translational Gastroenterology Unit in NDM’s Experimental Medicine Division.
Novel inhaled vaccine for tuberculosis to be trialled
News
16 January 2024
The Jenner Institute at NDM is conducting a new study using the Bacille Calmette-Guérin (BCG) vaccine, the only vaccine currently licensed against tuberculosis. People who have received the BCG vaccine previously will be given it again to compare whether giving it by inhalation is better at protecting people against tuberculosis than giving it through the skin.
Vaccine trial for deadly Nipah virus launched
News
11 January 2024
The first clinical trial participants received doses of the ChAdOx1 NipahB vaccine this week at the University of Oxford. This is the first-in-human trial of the vaccine, being developed by researchers at the Pandemic Sciences Institute.